Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Liabilities from Discontinued Operations (2016)

Aptevo Therapeutics' Liabilities from Discontinued Operations history spans 1 years, with the latest figure at 3928000.0 for Q4 2016.

  • For Q4 2016, Liabilities from Discontinued Operations changed N/A year-over-year to 3928000.0; the TTM value through Dec 2016 reached 3928000.0, changed N/A, while the annual FY2016 figure was 3928000.0, N/A changed from the prior year.
  • Liabilities from Discontinued Operations for Q4 2016 was 3928000.0 at Aptevo Therapeutics.
  • Across five years, Liabilities from Discontinued Operations topped out at 3928000.0 in Q4 2016 and bottomed at 3928000.0 in Q4 2016.